Skip to main content
Fig. 2 | Molecular Cancer

Fig. 2

From: CAR T-Cell therapy for the management of mantle cell lymphoma

Fig. 2

Different generations of CARs and manufacturing process of Tisagenlecleucel CAR. A. Generations of CAR. All the approved CARs are from the second generation. B. manufacturing process of Tisagenlecleucel CAR Abbreviations: scFv; variable fragments of a single-chain antibody, TM; transmembrane protein, CoStim; Costimulatory domain, IL; Interleukin

Back to article page

Molecular Cancer

ISSN: 1476-4598